Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Tsuji

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
Advances in Experimental Medicine and Biology|August 1, 2019
Rational Combinations of Polymyxins with Other AntibioticsPhillip J Bergen, Nicholas M Smith, Tyler B Bedard, et al.
Plos One|June 11, 2016
Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic ApproachSamira M Garonzik, Justin R Lenhard, Alan Forrest, et al.
The Journal of Antimicrobial Chemotherapy|November 9, 2014
Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosaVanessa E Rees, Jürgen B Bulitta, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2017
Influence of <i>rhlR</i> and <i>lasR</i> on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with AzithromycinZackery P Bulman, Neang S Ly, Justin R Lenhard, et al.
Infectious Diseases (London, England)|February 15, 2019
Successful cure of daptomycin-non-susceptible, vancomycin-intermediate Staphylococcus aureus prosthetic aortic valve endocarditis directed by synergistic in vitro time-kill studyZarchi E Sumon, Charles S Berenson, John A Sellick, et al.
International Journal of Antimicrobial Agents|October 30, 2016
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?Thien B Tran, Tony Velkov, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2009
Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumoniaYoriko Harigaya, Jürgen B Bulitta, Alan Forrest, et al.
Scientific Reports|March 31, 2017
Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Darren J Creek, Roger L Nation, et al.
Current Pharmaceutical Biotechnology|May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patientsJurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary DiseaseMelinda M Pettigrew, Brian T Tsuji, Janneane F Gent, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
Advances in Experimental Medicine and Biology|August 1, 2019
Rational Combinations of Polymyxins with Other AntibioticsPhillip J Bergen, Nicholas M Smith, Tyler B Bedard, et al.
Plos One|June 11, 2016
Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic ApproachSamira M Garonzik, Justin R Lenhard, Alan Forrest, et al.
The Journal of Antimicrobial Chemotherapy|November 9, 2014
Shape does matter: short high-concentration exposure minimizes resistance emergence for fluoroquinolones in Pseudomonas aeruginosaVanessa E Rees, Jürgen B Bulitta, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy|January 19, 2017
Influence of <i>rhlR</i> and <i>lasR</i> on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with AzithromycinZackery P Bulman, Neang S Ly, Justin R Lenhard, et al.
Infectious Diseases (London, England)|February 15, 2019
Successful cure of daptomycin-non-susceptible, vancomycin-intermediate Staphylococcus aureus prosthetic aortic valve endocarditis directed by synergistic in vitro time-kill studyZarchi E Sumon, Charles S Berenson, John A Sellick, et al.
International Journal of Antimicrobial Agents|October 30, 2016
Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?Thien B Tran, Tony Velkov, Roger L Nation, et al.
Antimicrobial Agents and Chemotherapy|July 15, 2009
Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillin-resistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumoniaYoriko Harigaya, Jürgen B Bulitta, Alan Forrest, et al.
Scientific Reports|March 31, 2017
Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumanniiMohd Hafidz Mahamad Maifiah, Darren J Creek, Roger L Nation, et al.
Current Pharmaceutical Biotechnology|May 11, 2011
Relevance of pharmacokinetic and pharmacodynamic modeling to clinical care of critically ill patientsJurgen B Bulitta, Cornelia B Landersdorfer, Alan Forrest, et al.
Antimicrobial Agents and Chemotherapy|May 4, 2016
Effect of Fluoroquinolones and Macrolides on Eradication and Resistance of Haemophilus influenzae in Chronic Obstructive Pulmonary DiseaseMelinda M Pettigrew, Brian T Tsuji, Janneane F Gent, et al.
Pageof 11